Injectable ampoules containing COVID-19 vaccine

FDA Registers AstraZeneca’s COVID-19 Vaccine

BANGKOK, Jan 22 (TNA) – The secretary-general of the Food and Drug Administration registered the COVID-19 vaccine that AstraZeneca Co developed, for the emergency use of 50,000 doses to cope with the disease spread crisis in the country.

FDA secretary-general Dr Paisarn Dunkum said the FDA registered the vaccine doses produced in Italy after the company had submitted its application that contained nearly 10,000 pages with the FDA on Dec 22.

Full story: tna.mcot.net

TNA

TN

The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.

Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

You May Also Like

More From Author

+ There are no comments

Add yours

Leave a Reply